On March 7, 2024, Thermo Fisher Scientific Inc. successfully completed its issuance of its inaugural CHF bonds in excess of CHF 1 bn, being the largest foreign Swiss franc bond issuance in seven years.

The issuance consisted of three tranches, the CHF 330 m 1.6525 per cent. bonds due 2028, CHF 415 m 1.8401 per cent. bonds due 2032 and the CHF 325 m 2.0375 per cent. bonds due 2036. The bonds are governed by Swiss law and have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the bonds, on the SIX Swiss Exchange. UBS Investment Bank, BNP Paribas (Suisse) SA, and Deutsche Bank AG London Branch, acting through Deutsche Bank AG Zurich Branch, acted as lead managers.

Homburger advised Thermo Fisher Scientific Inc. with respect to all legal, transactional and tax aspects of Swiss law. The Homburger team was led by Benjamin Leisinger and included Daniel Hulmann (both Capital Markets), as well as Stefan Oesterhelt (Tax).